Arufumi Shiota

688 total citations
38 papers, 472 citations indexed

About

Arufumi Shiota is a scholar working on Epidemiology, Infectious Diseases and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Arufumi Shiota has authored 38 papers receiving a total of 472 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 17 papers in Infectious Diseases and 10 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Arufumi Shiota's work include Streptococcal Infections and Treatments (9 papers), Nosocomial Infections in ICU (7 papers) and Pneumonia and Respiratory Infections (6 papers). Arufumi Shiota is often cited by papers focused on Streptococcal Infections and Treatments (9 papers), Nosocomial Infections in ICU (7 papers) and Pneumonia and Respiratory Infections (6 papers). Arufumi Shiota collaborates with scholars based in Japan, Australia and United States. Arufumi Shiota's co-authors include Yuka Yamagishi, Nobuhiro Asai, Mao Hagihara, Yusuke Koizumi, Daisuke Sakanashi, Hiroyuki Suematsu, Hideo Kato, Hiroki Watanabe, Hiroshige Mikamo and Hiroshige Mikamo and has published in prestigious journals such as Molecular and Cellular Biology, BMC Infectious Diseases and International Journal of Infectious Diseases.

In The Last Decade

Arufumi Shiota

37 papers receiving 470 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Arufumi Shiota Japan	14	179	175	77	61	47	38	472
Matthew Sims United States	15	197 1.1×	204 1.2×	137 1.8×	30 0.5×	84 1.8×	42	662
Wendi Jiang China	7	232 1.3×	282 1.6×	91 1.2×	44 0.7×	68 1.4×	12	588
Paola Del Giacomo Italy	9	83 0.5×	87 0.5×	67 0.9×	35 0.6×	65 1.4×	18	421
Noah Wald‐Dickler United States	11	237 1.3×	174 1.0×	42 0.5×	61 1.0×	62 1.3×	20	466
Jyotsna Agarwal India	10	135 0.8×	82 0.5×	42 0.5×	35 0.6×	37 0.8×	54	304
Masayuki Nigo United States	15	158 0.9×	167 1.0×	36 0.5×	39 0.6×	67 1.4×	40	494
Benjamin Gaborit France	15	232 1.3×	209 1.2×	99 1.3×	36 0.6×	52 1.1×	47	540
Min Hyuk Choi South Korea	13	101 0.6×	147 0.8×	61 0.8×	35 0.6×	61 1.3×	33	455
Archana Angrup India	13	155 0.9×	156 0.9×	67 0.9×	71 1.2×	86 1.8×	92	486
Sanghamitra Padhi India	12	136 0.8×	160 0.9×	56 0.7×	119 2.0×	29 0.6×	33	508

Countries citing papers authored by Arufumi Shiota

Since Specialization

Citations

This map shows the geographic impact of Arufumi Shiota's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Arufumi Shiota with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Arufumi Shiota more than expected).

Fields of papers citing papers by Arufumi Shiota

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Arufumi Shiota. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Arufumi Shiota. The network helps show where Arufumi Shiota may publish in the future.

Co-authorship network of co-authors of Arufumi Shiota

This figure shows the co-authorship network connecting the top 25 collaborators of Arufumi Shiota. A scholar is included among the top collaborators of Arufumi Shiota based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Arufumi Shiota. Arufumi Shiota is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Shibata, Yuichi, et al.. (2024). Clinical efficacy and safety assessment of tedizolid using therapeutic drug monitoring. Journal of Infection and Chemotherapy. 31(3). 102582–102582. 1 indexed citations

Shibata, Yuichi, Mao Hagihara, Nobuhiro Asai, et al.. (2023). A Retrospective Study to Compare the Incidence of Hyponatremia after Administration between Linezolid and Tedizolid. Antibiotics. 12(2). 345–345. 1 indexed citations

Shiota, Arufumi, Nobuhiro Asai, Yusuke Koizumi, et al.. (2022). Risk factors of first recurrence of Clostridioides difficile infection. Anaerobe. 75. 102556–102556. 4 indexed citations

Asai, Nobuhiro, Wataru Ohashi, Takaaki Kishino, et al.. (2021). The combined score of quick SOFA and the charlson comorbidity index could be a poor prognostic indicator for in-hospital mortality among patients with necrotizing fasciitis. Journal of Infection and Chemotherapy. 27(6). 919–923. 3 indexed citations

Asai, Nobuhiro, Wataru Ohashi, Daisuke Sakanashi, et al.. (2021). Combination of Sequential Organ Failure Assessment (SOFA) score and Charlson Comorbidity Index (CCI) could predict the severity and prognosis of candidemia more accurately than the Acute Physiology, Age, Chronic Health Evaluation II (APACHE II) score. BMC Infectious Diseases. 21(1). 77–77. 30 indexed citations

Asai, Nobuhiro, Hiroyuki Suematsu, Wataru Ohashi, et al.. (2021). Ceftriaxone versus tazobactam/piperacillin and carbapenems in the treatment of aspiration pneumonia: A propensity score matching analysis. Journal of Infection and Chemotherapy. 27(10). 1465–1470. 12 indexed citations

Koizumi, Yusuke, Tomoko Ohno, Daisuke Sakanashi, et al.. (2021). An unexpected case of Cardiobacterium valvarum prosthetic arthritis without cardiac lesions: Case report and literature review. Journal of Infection and Chemotherapy. 27(5). 747–750. 1 indexed citations

Shiota, Arufumi & Hiroshige Mikamo. (2021). Expectations for Pharmacists and Pharmacy Education in AST Activities. YAKUGAKU ZASSHI. 141(11). 1249–1251.

Asai, Nobuhiro, Daisuke Sakanashi, Hiroyuki Suematsu, et al.. (2020). Observational study in a single institute in Japan: How many community-onset pneumonia patients would have Clostridioides difficile infections after treatment?. Journal of Infection and Chemotherapy. 26(10). 1104–1106. 4 indexed citations

10.

Koizumi, Yusuke, Daisuke Sakanashi, Hiroki Watanabe, et al.. (2020). Can presepsin uniformly respond to various pathogens? - an in vitro assay of new sepsis marker -. BMC Immunology. 21(1). 33–33. 9 indexed citations

11.

Asai, Nobuhiro, Daisuke Sakanashi, Akiko Nakamura, et al.. (2020). Clinical manifestations and radiological features by chest computed tomographic findings of a novel coronavirus disease-19 pneumonia among 92 patients in Japan. Journal of Microbiology Immunology and Infection. 54(4). 748–751. 13 indexed citations

12.

Asai, Nobuhiro, Daisuke Sakanashi, Hiroyuki Suematsu, et al.. (2019). Infective endocarditis caused by Cardiobacterium hominis endocarditis: A case report and review of the literature. Journal of Infection and Chemotherapy. 25(8). 626–629. 5 indexed citations

13.

Asai, Nobuhiro, Daisuke Sakanashi, Hiroyuki Suematsu, et al.. (2019). Clinical manifestations and risk factors of community-onset Acinetobacter species pneumonia in Japan; case control study in a single institute in Japan. Journal of Infection and Chemotherapy. 25(8). 639–642. 6 indexed citations

14.

Shiota, Arufumi, Nobuhiro Asai, Yusuke Koizumi, et al.. (2019). Extended drip infusion of peripheral parental nutrition containing amino acids might be associated with Bacillus cereus bloodstream infection. American Journal of Infection Control. 47(9). 1154–1156. 4 indexed citations

15.

Asai, Nobuhiro, Hiroyuki Suematsu, Daisuke Sakanashi, et al.. (2019). A severe case of Streptococcal pyogenes empyema following influenza A infection. BMC Pulmonary Medicine. 19(1). 25–25. 5 indexed citations

16.

Asai, Nobuhiro, Hiroyuki Suematsu, Atsuko Yamada, et al.. (2019). Brevibacterium paucivorans bacteremia: case report and review of the literature. BMC Infectious Diseases. 19(1). 344–344. 23 indexed citations

17.

Hagihara, Mao, Hideo Kato, Midori Soda, et al.. (2019). In vivo study assessed meropenem and amikacin combination therapy against carbapenem-resistant and carbapenemase-producing Enterobacteriaceae strains. Journal of Infection and Chemotherapy. 26(1). 1–7. 10 indexed citations

18.

Asai, Nobuhiro, Yusuke Koizumi, Atsuko Yamada, et al.. (2019). Pantoea dispersa bacteremia in an immunocompetent patient: a case report and review of the literature. Journal of Medical Case Reports. 13(1). 33–33. 36 indexed citations

19.

Asai, Nobuhiro, Hiroki Watanabe, Arufumi Shiota, et al.. (2017). Could qSOFA and SOFA score be correctly estimating the severity of healthcare-associated pneumonia?. Journal of Infection and Chemotherapy. 24(3). 228–231. 19 indexed citations

20.

Hagihara, Mao, Yuka Yamagishi, Hideo Kato, et al.. (2017). Frequency of Treponema pallidum invasion into cerebrospinal fluid in primary or secondary early-stage syphilis. Journal of Infection and Chemotherapy. 24(5). 404–406. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact